PharVision Advisers’s Palantir PLTR Stock Holding History

PharVision Advisers’s Portfolio PLTR Stock Details PLTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-1,988	Closed	-$271K	–	763
2025 Q2	$271K	Buy	+1,988	New	+$233K	0.39%	102
2025 Q1	–	Sell	-4,558	Closed	-$345K	–	463
2024 Q4	$345K	Buy	+4,558	New	+$265K	0.29%	112

Other funds holding PLTR

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

PharVision Advisers's PLTR Position: Q3 2025 in Review

PharVision Advisers sold out of Palantir (PLTR) in Q3 2025, closing a stake of 1,988 shares — an estimated $271K sold.

PharVision Advisers first reported a position in PLTR in Q4 2024 and held it in 2 quarters. The position peaked at $345K in Q4 2024. 2,831 funds tracked by Wall St. Rank hold PLTR as of Q3 2025.

PharVision Advisers reported no remaining Palantir position as of Q3 2025 after selling out during the quarter.
PharVision Advisers sold 1,988 Palantir shares in Q3 2025, an estimated $271K.
PharVision Advisers first reported a position in Palantir in Q4 2024 and held it in 2 quarters.
PharVision Advisers's Palantir position peaked at $345K in Q4 2024.
2,831 funds tracked by Wall St. Rank held Palantir as of Q3 2025.

Based on PharVision Advisers's 13F filing for Q3 2025, filed 17 Nov 2025.